SEC Form 4 · accession 0001140361-16-066548
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brad Vale
Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $63.39 | May 18, 2016 | A | 3,240 | A | — | May 18, 2026 | Common Stock | 3,240 | 3,240 | D |
Explanation of responses
- F11/12th of the shares subject to the option vest on each monthly anniversary measured from May 18, 2016 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the first anniversary of the Vesting Commencement Date.